Cagrilintide 5mg
Order Cagrilintide 5mg for Research Applications
Cagrilintide is a synthetic peptide analog within the amylin class, engineered with lipid-based modifications that support prolonged interaction with target receptors in experimental systems. This 37-amino-acid peptide incorporates acylation features that enhance membrane affinity and extend functional activity in laboratory assays. Supplied as a 10mg lyophilized powder, it is suited for studies requiring controlled concentration gradients and receptor engagement analysis.
Mechanistic Overview
In preclinical models, cagrilintide interacts with amylin receptor complexes, exhibiting extended binding characteristics due to its lipophilic modifications. These properties contribute to sustained receptor activation in cell-based systems, particularly within G-protein coupled receptor pathways involving calcitonin receptor and receptor activity-modifying protein (RAMP) complexes. Higher dosing formats allow researchers to evaluate signaling duration, receptor occupancy, and pathway interactions across different cellular environments.
Summary of Research Findings
Work by Ferrannini et al. (2021) examined pharmacokinetic behavior of modified amylin analogs in receptor-binding and tissue models. Research published by Nauck et al. (Frontiers in Endocrinology, 2020) explored signaling pathways involving calcitonin receptor systems and RAMP specificity. Additional studies have reported concentration-dependent modulation of intracellular calcium flux and cyclic AMP signaling in engineered cell systems exposed to amylin analogs.
Product Details – Cagrilintide
Supplied as 10mg of lyophilized white peptide powder per vial. Recommended storage conditions include refrigeration (2–8°C) or freezing (-20°C) in a dry, light-protected environment. Reconstitution is typically performed using sterile phosphate-buffered solutions (pH ~7.4) or bacteriostatic saline. Stability may extend up to 36 months when stored appropriately. Purity is generally ≥98%, confirmed via LC-MS and analytical HPLC methods.
Research Use Statement
This material is intended strictly for laboratory research use. It is not approved for human consumption, clinical application, or therapeutic purposes. All described effects are based on preclinical investigations. Proper use requires adherence to institutional safety protocols and regulatory standards.
